Current Market Information

Last Trade Price (LTP) 25.10 Last Trade Date 08 June, 2023 Change 2.03 % Open Price 24.60 Day's Range 24.40 - 26.40     Total Trade 15 Total Volume 6799 Close Price 25.10 Yesterday Close Price 24.60 Market Capital in BDT (mn) 2605.556

Contact Information

Designation Name Mobile Number Email Chairman Mrs. Naim Fatema 01714073477 directorspl@gmail.com MD Dr. Md. Badrul Haque Rukan 01711920546 b.haquerukon58@gmail.com CFO Mr. Monjur Alam 01623618639 cfo.silcopharma@gmail.com Company Secretary Mr. Tingku Ranjan Sarker 01716394060 trt.tinku@gmail.com Office Address Silco Pharmaceuticals Ltd. Nurani-41, Ban-kalapara,Subid Bazar,Sylhet Subid Bazar,Sylhet-3100 Phone : +88-0821-722241, 0821-2833054 Fax : Email : info@silcopharma.com Website : http://www.silcopharma.com/ Factory Address BSCIC Industrial Estate, Khadimnagor, Sylhet

Basic Information

Authorized Capital in BDT* (mn) 1,050.00 Paid-up Capital in BDT* (mn) 1,038.07 Face Value 10 Paid up Share 103807000     Market Lot 1 Sector PHARMA & CHEMICALS Market Category B

Other Information

Listing Year 2019 Debut Trade Date 13 June, 2019 Type of Instrument     52 Week's Range 23.00 - 29.00 Year End 202206 Reserve / Surplus(mn) 1251.24 Remarks Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 30-Apr, 2023 39.0082 0 12.1784 0 48.8134 As on 31-Mar, 2023 39.0082 0 12.1071 0 48.8847 As on 28-Feb, 2023 39.0082 0 11.6677 0 49.3241 As on 30-Jun, 2022 (year ended) 39.1191 0 8.9945 0 51.8864     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company         Half Year End (HY) Information  202212 HY Net Turnover(mn)  235.64 HY Net Profit after tax(mn)  45.43 HY EPS  0.44  AGM Information   AGM Date  10 January, 2023 Record Date  05 December, 2022 Dividend(%)  5.00(Cash for all shareholders excluding sponsors and directors) Bonus Issue  10% 2019

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2022	0.81	0	0	0	21.95	0	84.45	0	5%C	1.89
2021	0.82	0	0	0	21.85	0	84.65	0	10%C	3.83
2020	0.8	0	0	0	21.64	0	83.18	0	10%C	4.46
2019	2.28	0	0	0	23.12	0	162.48	0	2%C,10%B	0.81
2018	1.64	0	1.12	0	27.05	18.45	105.36	0		0

Financial Statements
Quarterly Financial Statement	http://www.silcopharma.com/quarterly-reports/
Price Sensitive Information	http://www.silcopharma.com/price-sensitive-information/

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To